NCPI
NIH Cloud PlatformInteroperability Effort
searchclose
YouYubeGitHubSlack

Study

arrow_backDatasets

COVID-19 ACTIV-4 ACUTE: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV4A)

phs002694.v1.p1dbGapdbGap FHIR

Description

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients.

Summary

PlatformsBDC
Consent CodesGRU
Focus / DiseasesCOVID-19
Study DesignInterventional
Data Types--
Subjects1,083

Applying For Access

dbGaP FAQdbGaP Access Request Video Tutorial